» Articles » PMID: 39516498

Normal Tissue Transcriptional Signatures for Tumor-type-agnostic Phenotype Prediction

Overview
Journal Sci Rep
Specialty Science
Date 2024 Nov 8
PMID 39516498
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer transcriptional patterns reflect both unique features and shared hallmarks across diverse cancer types, but whether differences in these patterns are sufficient to characterize the full breadth of tumor phenotype heterogeneity remains an open question. We hypothesized that these shared transcriptomic signatures reflect repurposed versions of functional tasks performed by normal tissues. Starting with normal tissue transcriptomic profiles, we use non-negative matrix factorization to derive six distinct transcriptomic phenotypes, called archetypes, which combine to describe both normal tissue patterns and variations across a broad spectrum of malignancies. We show that differential enrichment of these signatures correlates with key tumor characteristics, including overall patient survival and drug sensitivity, independent of clinically actionable DNA alterations. Additionally, we show that in HR+/HER2- breast cancers, metastatic tumors adopt transcriptomic signatures consistent with the invaded tissue. Broadly, our findings suggest that cancer often arrogates normal tissue transcriptomic characteristics as a component of both malignant progression and drug response. This quantitative framework provides a strategy for connecting the diversity of cancer phenotypes and could potentially help manage individual patients.

Citing Articles

Metabolic Objectives and Trade-Offs: Inference and Applications.

Lin D, Khattar S, Chandrasekaran S Metabolites. 2025; 15(2).

PMID: 39997726 PMC: 11857637. DOI: 10.3390/metabo15020101.

References
1.
Rashid N, Grible J, Clevenger C, Harrell J . Breast cancer liver metastasis: current and future treatment approaches. Clin Exp Metastasis. 2021; 38(3):263-277. PMC: 8211035. DOI: 10.1007/s10585-021-10080-4. View

2.
Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

3.
Mundi P, Dela Cruz F, Grunn A, Diolaiti D, Mauguen A, Rainey A . A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies. Cancer Discov. 2023; 13(6):1386-1407. PMC: 10239356. DOI: 10.1158/2159-8290.CD-22-1020. View

4.
. Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490(7418):61-70. PMC: 3465532. DOI: 10.1038/nature11412. View

5.
. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020; 369(6509):1318-1330. PMC: 7737656. DOI: 10.1126/science.aaz1776. View